A detailed history of Monarch Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Monarch Capital Management Inc holds 24,458 shares of BMY stock, worth $1.37 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
24,458
Previous 24,228 0.95%
Holding current value
$1.37 Million
Previous $1.01 Million 25.75%
% of portfolio
0.35%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$39.66 - $51.75 $9,121 - $11,902
230 Added 0.95%
24,458 $1.27 Million
Q2 2024

Jul 24, 2024

SELL
$40.25 - $52.99 $34,776 - $45,783
-864 Reduced 3.44%
24,228 $1.01 Million
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $95 - $108
-2 Reduced 0.01%
25,092 $1.36 Million
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $10,908 - $13,016
-225 Reduced 0.89%
25,094 $1.29 Million
Q3 2022

Oct 20, 2022

SELL
$0.13 - $76.84 $12 - $7,376
-96 Reduced 0.38%
25,319 $1.8 Million
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $2,396 - $2,639
-33 Reduced 0.13%
25,415 $1.96 Million
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $2,414 - $2,629
-39 Reduced 0.15%
25,448 $1.7 Million
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $6,409 - $7,262
-111 Reduced 0.43%
25,487 $1.58 Million
Q3 2020

Oct 22, 2020

SELL
$57.43 - $63.64 $5,743 - $6,364
-100 Reduced 0.39%
25,598 $1.54 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $61,946 - $72,421
-1,130 Reduced 4.21%
25,698 $1.51 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $41,713 - $60,619
-899 Reduced 3.24%
26,828 $1.5 Million
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $92,268 - $120,356
1,875 Added 7.25%
27,727 $1.78 Million
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $4,512 - $5,380
-100 Reduced 0.39%
25,852 $1.23 Million
Q4 2018

Jan 23, 2019

SELL
$48.76 - $63.23 $14,628 - $18,969
-300 Reduced 1.14%
25,952 $1.35 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $13,797 - $15,562
-250 Reduced 0.94%
26,252 $1.63 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $30,823 - $38,417
-610 Reduced 2.25%
26,502 $1.47 Million
Q1 2018

Apr 18, 2018

SELL
$59.92 - $68.98 $7,490 - $8,622
-125 Reduced 0.46%
27,112 $1.72 Million
Q4 2017

Jan 31, 2018

SELL
$59.94 - $65.35 $59,940 - $65,349
-1,000 Reduced 3.54%
27,237 $1.67 Million
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $1.56 Million - $1.8 Million
28,237
28,237 $1.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Monarch Capital Management Inc Portfolio

Follow Monarch Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.